Proteomic analysis of pleural effusion from lung adenocarcinoma patients by shotgun strategy

被引:15
|
作者
Sheng, Shu-hong [1 ]
Zhu, Hui-li [1 ]
机构
[1] Fudan Univ, Huadong Hosp, Dept Resp Med, Shanghai 200040, Peoples R China
关键词
Biomarker; Malignant pleural effusion; Proteomic; Shotgun; MASS-SPECTROMETRY; 2-DIMENSIONAL ELECTROPHORESIS; CELL-LINES; GENE; PROTEINS; IDENTIFICATION; RECOGNITION; DISCOVERY; DYNAMICS; DOMAINS;
D O I
10.1007/s12094-013-1054-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To construct a protein catalogue of malignant pleural effusion from lung adenocarcinoma patients and to screen the potential candidates of biomarkers for diagnostic value in human lung adenocarcinoma. Five malignant pleural effusion samples of lung adenocarcinoma patients were collected from January 2009 to September. A composite sample was analyzed using shotgun strategy. Pleural effusion samples were separated by means of SDS-PAGE. Proteomic analysis was performed by 1D-LC-MS/MS, and then the proteins were identified using SEQUEST software and protein database search. Among 230 unique proteins, 123 proteins were identified with higher confidence levels (at least two unique peptide sequences matched). Most of these proteins have been reported in plasma. However, there are 7 proteins, including JUP protein, suprabasin, annexin A2, transforming growth factor-beta-induced protein ig-h3 (beta ig-h3), V-set and immunoglobulin domain-containing protein 4 precursor, ifapsoriasin 2 and actin, cytoplasmic 1 have not been reported in serum. Seven proteins may represent potential candidates of biomarkers. Annexin A2 is of special interest since it may play a role in the regulation of intercellular adhesion and cell proliferation.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 50 条
  • [41] Proteomic analysis of the skeletal muscles from dysferlinopathy patients
    Choi, Young-Chul
    Hong, Ji-Man
    Park, Kee Duk
    Shin, Ha Young
    Kim, Seung Min
    Park, Hyung Jun
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 71 : 186 - 190
  • [42] Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: Correlations with patient survival and pleural effusion control
    Qian, Q.
    Zhan, P.
    Sun, W. K.
    Zhang, Y.
    Song, Y.
    Yu, L. K.
    NEOPLASMA, 2012, 59 (04) : 433 - 439
  • [43] The Prognosis of Lung Cancer Patients with Unexpected Malignant Pleural Effusion and Without Pleural Dissemination Detected at Thoracotomy
    Yamamichi, T.
    Harada, M.
    Asakawa, A.
    Okui, M.
    Horio, H.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S909 - S909
  • [44] Quantitative Proteomic Analysis of Metastasis-Associated Proteins in Human Primary Lung Adenocarcinoma
    Liu Ying-Fu
    Xiao Zhi-Qiang
    Zhang Peng-Fei
    Li Mao-Yu
    Li Cui
    Peng Fang
    Yu Yan-Hui
    Yi Hong
    Chen Zhu-Chu
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2009, 36 (04) : 448 - 457
  • [45] Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer
    Shojaee, Samira
    Singh, Inderjit
    Solsky, Ian
    Nana-Sinkam, Patrick
    RESPIRATION, 2019, 98 (03) : 198 - 202
  • [46] Pleural effusion levels of DJ-1 are increased in elderly lung cancer patients with malignant pleural effusions
    Vavougios, George
    Kerenidi, Theodora
    Tsilioni, Irene
    Zarogiannis, Sotirios G.
    Gourgoulianis, Konstantinos I.
    REDOX REPORT, 2015, 20 (06) : 254 - 258
  • [47] The Thoracoscopic Talc Pleurodesis with Intraoperative Pleural Biopsy - A Retrospective Analysis in Patients with Malignant Pleural Effusion
    Hoksch, B.
    Seidel, N.
    Beshay, M.
    Schmid, R. A.
    ZENTRALBLATT FUR CHIRURGIE, 2010, 135 (01): : 54 - 58
  • [48] Indwelling Pleural Catheter Drainage Strategy for Malignant Effusion: A Cost-Effectiveness Analysis
    Shafiq, Majid
    Simkovich, Suzanne
    Hossen, Shakir
    Feller-Kopman, David J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (06) : 746 - 753
  • [49] Copy number gain in recurrent anaplastic lymphoma kinase (ALK) rearrangement-lung adenocarcinoma in the pleural effusion
    Abe, Hideyuki
    Kawahara, Akihiko
    Azuma, Koichi
    Murakami, Yuichi
    Takase, Yorihiko
    Naito, Yoshiki
    Akiba, Jun
    DIAGNOSTIC CYTOPATHOLOGY, 2018, 46 (09) : 744 - 747
  • [50] Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion
    Pernemalm, Maria
    De Petris, Luigi
    Eriksson, Hanna
    Branden, Eva
    Koyi, Hirsh
    Kanter, Lena
    Lewensohn, Rolf
    Lehtio, Janne
    PROTEOMICS, 2009, 9 (13) : 3414 - 3424